Endoscopic ultrasound-guided rendezvous in benign biliary or pancreatic disorders with a 22-gauge needle and a 0.018-inch guidewire

Background and study aims The aim of this study was to assess the efficacy and safety of endoscopic ultrasound-guided rendezvous (EUS-RV) for benign biliary or pancreatic disorders with a 22-gauge needle and a 0.018-inch guidewire. Patients and methods Patients who underwent EUS-RV after...

Full description

Bibliographic Details
Main Authors: Belén Martínez, Juan Martínez, Juan Antonio Casellas, José R. Aparicio
Format: Article
Language:English
Published: Georg Thieme Verlag KG 2019-08-01
Series:Endoscopy International Open
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/a-0918-5931
_version_ 1818265814005972992
author Belén Martínez
Juan Martínez
Juan Antonio Casellas
José R. Aparicio
author_facet Belén Martínez
Juan Martínez
Juan Antonio Casellas
José R. Aparicio
author_sort Belén Martínez
collection DOAJ
description Background and study aims The aim of this study was to assess the efficacy and safety of endoscopic ultrasound-guided rendezvous (EUS-RV) for benign biliary or pancreatic disorders with a 22-gauge needle and a 0.018-inch guidewire. Patients and methods Patients who underwent EUS-RV after failed biliary or pancreatic cannulation for benign disorder were candidates for this study. For EUS-RV, a 22-gauge needle and a 0.018-inch guidewire were used. Inclusion criteria were unsuccessful biliary or pancreatic cannulation for therapeutic endoscopic retrograde cholangiopancreatography (ERCP) with benign biliary or pancreatic obstruction. Exclusion criteria included malignant biliary or pancreatic obstruction, inaccessible papilla due to surgically altered upper gastrointestinal anatomy or duodenal stricture, and previous sphincterotomy and/or biliary stent placement. The primary outcome was the technical success rate of biliary or pancreatic cannulation, and the secondary outcome was the rate of adverse events. Results Thirty-one patients were evaluated. The overall technical success rate was 80.6 % (81.5 % in biliary and 75 % in pancreatic cases). Adverse events (AEs) were identified in 12.9 % of patients, including one with biliary peritonitis, one with abdominal pain and one with severe pancreatitis plus pneumomediastinum. Only one of the AEs (3.3 %) was directly related to the rendezvous procedure. Conclusions EUS-RV may be a safe and feasible salvage method for unsuccessful cannulation for benign disorders. Use of a 22-gauge needle with a 0.018-inch guidewire may be the first option for benign pathology.
first_indexed 2024-12-12T19:56:47Z
format Article
id doaj.art-c0862d921f1e46378e2b0345b5ed1bbd
institution Directory Open Access Journal
issn 2364-3722
2196-9736
language English
last_indexed 2024-12-12T19:56:47Z
publishDate 2019-08-01
publisher Georg Thieme Verlag KG
record_format Article
series Endoscopy International Open
spelling doaj.art-c0862d921f1e46378e2b0345b5ed1bbd2022-12-22T00:13:51ZengGeorg Thieme Verlag KGEndoscopy International Open2364-37222196-97362019-08-010708E1038E104310.1055/a-0918-5931Endoscopic ultrasound-guided rendezvous in benign biliary or pancreatic disorders with a 22-gauge needle and a 0.018-inch guidewireBelén Martínez0Juan Martínez1Juan Antonio Casellas2José R. Aparicio3Servicio Aparato Digestivo. Hospital Universitario del Vinalopó, Elche, Alicante, SpainUnidad de Endoscopia. Servicio de Aparato Digestivo, Hospital General Universitario de Alicante, ISABIAL, Alicante, SpainUnidad de Endoscopia. Servicio de Aparato Digestivo, Hospital General Universitario de Alicante, ISABIAL, Alicante, SpainUnidad de Endoscopia. Servicio de Aparato Digestivo, Hospital General Universitario de Alicante, ISABIAL, Alicante, SpainBackground and study aims The aim of this study was to assess the efficacy and safety of endoscopic ultrasound-guided rendezvous (EUS-RV) for benign biliary or pancreatic disorders with a 22-gauge needle and a 0.018-inch guidewire. Patients and methods Patients who underwent EUS-RV after failed biliary or pancreatic cannulation for benign disorder were candidates for this study. For EUS-RV, a 22-gauge needle and a 0.018-inch guidewire were used. Inclusion criteria were unsuccessful biliary or pancreatic cannulation for therapeutic endoscopic retrograde cholangiopancreatography (ERCP) with benign biliary or pancreatic obstruction. Exclusion criteria included malignant biliary or pancreatic obstruction, inaccessible papilla due to surgically altered upper gastrointestinal anatomy or duodenal stricture, and previous sphincterotomy and/or biliary stent placement. The primary outcome was the technical success rate of biliary or pancreatic cannulation, and the secondary outcome was the rate of adverse events. Results Thirty-one patients were evaluated. The overall technical success rate was 80.6 % (81.5 % in biliary and 75 % in pancreatic cases). Adverse events (AEs) were identified in 12.9 % of patients, including one with biliary peritonitis, one with abdominal pain and one with severe pancreatitis plus pneumomediastinum. Only one of the AEs (3.3 %) was directly related to the rendezvous procedure. Conclusions EUS-RV may be a safe and feasible salvage method for unsuccessful cannulation for benign disorders. Use of a 22-gauge needle with a 0.018-inch guidewire may be the first option for benign pathology.http://www.thieme-connect.de/DOI/DOI?10.1055/a-0918-5931
spellingShingle Belén Martínez
Juan Martínez
Juan Antonio Casellas
José R. Aparicio
Endoscopic ultrasound-guided rendezvous in benign biliary or pancreatic disorders with a 22-gauge needle and a 0.018-inch guidewire
Endoscopy International Open
title Endoscopic ultrasound-guided rendezvous in benign biliary or pancreatic disorders with a 22-gauge needle and a 0.018-inch guidewire
title_full Endoscopic ultrasound-guided rendezvous in benign biliary or pancreatic disorders with a 22-gauge needle and a 0.018-inch guidewire
title_fullStr Endoscopic ultrasound-guided rendezvous in benign biliary or pancreatic disorders with a 22-gauge needle and a 0.018-inch guidewire
title_full_unstemmed Endoscopic ultrasound-guided rendezvous in benign biliary or pancreatic disorders with a 22-gauge needle and a 0.018-inch guidewire
title_short Endoscopic ultrasound-guided rendezvous in benign biliary or pancreatic disorders with a 22-gauge needle and a 0.018-inch guidewire
title_sort endoscopic ultrasound guided rendezvous in benign biliary or pancreatic disorders with a 22 gauge needle and a 0 018 inch guidewire
url http://www.thieme-connect.de/DOI/DOI?10.1055/a-0918-5931
work_keys_str_mv AT belenmartinez endoscopicultrasoundguidedrendezvousinbenignbiliaryorpancreaticdisorderswitha22gaugeneedleanda0018inchguidewire
AT juanmartinez endoscopicultrasoundguidedrendezvousinbenignbiliaryorpancreaticdisorderswitha22gaugeneedleanda0018inchguidewire
AT juanantoniocasellas endoscopicultrasoundguidedrendezvousinbenignbiliaryorpancreaticdisorderswitha22gaugeneedleanda0018inchguidewire
AT joseraparicio endoscopicultrasoundguidedrendezvousinbenignbiliaryorpancreaticdisorderswitha22gaugeneedleanda0018inchguidewire